Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Q1A(R2) Stability testing of new drug substances and products. ICH Guidance for industry, Geneva. 2003. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q1ar2-stability-testing-new-drug-substances-and-products. Accessed 21 Sept 2023.
2. Pani NR, Nath LK, Acharya S. Compatibility studies of nateglinide with excipients in immediate release tablets. Acta Pharm. 2011;561:237–47.
3. Malan CEP, de Villiers MM, Lötter AP. Evaluation of compatibility of tablet excipients with albendazole and closantel using DSC and HPLC. Drug Dev and Ind Pharm. 1997;23:533–7.
4. Malan CEP, de Villiers MM, Lötter AP. Application of differential scanning calorimetry and high performance liquid chromatography to determine the effects of mixture composition and preparation during the evaluation of niclosamide-excipient compatibility. J Pharm Biomed Anal. 1997;15:549–57.
5. Araújo AAS, Storpirtis S, Mercuri LP, Carvalho FMS, Filho MDS, Matos JR. Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms. Int J Pharm. 2003;260:303–14.